Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer

Int J Colorectal Dis. 2004 Jan;19(1):18-22. doi: 10.1007/s00384-003-0494-z. Epub 2003 Jun 21.

Abstract

Background and aims: Recent studies have shown that nuclear factor-kappa B/RelA (NF-kappa B/RelA) is involved in tumor angiogenesis. This study examined whether NF-kappa B/RelA expression is associated with vascular endothelial growth factor (VEGF) expression and microvessel density in human colorectal cancer.

Materials and methods: Ten specimens from normal colorectal mucosa and 52 colorectal adenocarcinomas were obtained by surgery or endoscopy. Immunohistochemical expression of NF-kappa B/RelA, VEGF, and CD34 was detected on paraffin-embedded tissue sections.

Results: NF-kappa B/RelA and VEGF were significantly overexpressed and associated with microvessel density in colorectal cancer. A significant association was found between NF-kappa B/RelA and VEGF expression. Clinicopathological features were not correlated with NF-kappa B/RelA, VEGF expression, or microvessel density.

Conclusion: Our results suggest that increased expression of NF-kappa B/RelA contributes to tumor angiogenesis in colorectal cancer. VEGF may play an important role in mediating the NF-kappa B/RelA angiogenic pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / blood supply*
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD34 / metabolism
  • Case-Control Studies
  • Colorectal Neoplasms / blood supply*
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / pathology
  • Female
  • Humans
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Male
  • Middle Aged
  • NF-kappa B / metabolism*
  • Neovascularization, Pathologic / metabolism*
  • Tumor Cells, Cultured
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antigens, CD34
  • NF-kappa B
  • Vascular Endothelial Growth Factor A